Home › Company will create new swine vaccines based on advanced mucosal technology
 

Keywords :   


Company will create new swine vaccines based on advanced mucosal technology

2015-07-07 21:29:38| National Hog Farmer

Aptimmune Biologics, a mucosal vaccine company developing novel swine vaccines for PRRSV and influenza virus, has received $2.75 million of funding from Arsenal Capital Management, Fox Ventures LLC, and a group of Midwest angel investors. “PRRSV and influenza virus are a growing threat to swine health worldwide. Their combined annual economic impact on the U.S. swine industry alone is over $1.4 billion. Our new vaccine portfolio will change the management of these diseases, significantly improve swine health and producer productivity,” said Dr. read more

Tags: advanced company based create

Category:Agriculture and Forestry

Latest from this category

All news
22.11Hay supply is likely up, but winter feed costs still matter
22.11Future plans for US SHIP and USDA's role explored
22.11Strategy for increasing feed efficiency for cows
22.11Top 3 myths of cattle marketing
22.11Carcass management workshop gets pork producers FAD prepared
22.11Are we close to eliminating Mycoplasma hyopneumoniae from the U.S. swine herd?
22.11Costa to challenge Scott for top House Agriculture Democrat role
22.11Farm Progress America, Nov. 22, 2024
Agriculture and Forestry »
22.11SHIMANO BT Master 11AP)
22.11
22.11
22.11GOLDWIN
22.11Qi10 TOUR 5W WF
22.11
22.11GX HR
22.11 GEORGIA
More »